Fresenius - the health care group
The Fresenius Group consists of the following four business segments that are responsible for their own business operations worldwide: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed.
Latest news
Fresenius Medical Care successfully placed three tranches of U.S. dollar and euro-denominated senior unsecured notes (together the “senior notes”). Proceeds amounting to approximately $1.82 billion are intended to be used for acquisitions, including the acquisition of Liberty Dialysis Holdings, Inc., to refinance indebtedness and for general corporate purposes.
>>>Fresenius Medical Care today announced its intention to sell U.S. dollar and euro-denominated senior unsecured notes (together the “senior notes”) of $1.2 billion and €250 million. The tranches will have a maturity between 7.5 and 10 years.
>>>Fresenius Medical Care is entering the dialysis services market in Ecuador. Effective December 1, the company has acquired eight private dialysis clinics which currently treat over 1,000 dialysis patients.
>>>After a strong third quarter, Fresenius expects to achieve excellent fourth quarter earnings growth in 2011. In particular, Fresenius Kabi and Fresenius Helios have continued to perform strongly.
>>>Fresenius Medical Care today announced revised outlook for revenue to be approximately 1.0% to 2.0% below the US-Dollar 13 billion benchmark. The impact on the revenue is predominately due to significant weakening of the Euro and other currencies against the US-Dollar in the fourth quarter of 2011.
>>>